Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective small-molecule inhibitors of CDK4 identified at Roche

July 15, 2003

AVP-893: a prototype of a novel class of antitumor agents designed at Avanir

July 15, 2003

Novel methionine aminopeptidase type 2 inhibitors discovered by GSK scientists

July 15, 2003

Optimization of CDK-2 inhibitor series as orally active antitumor agents

July 14, 2003

BMS presents second-generation farnesyltransferase inhibitors at AACR meeting

July 14, 2003

Ivax initiates phase II trial of talampanel for brain cancer

July 14, 2003

Enrollment completed for phase I/II study of 131I-TM-601 in glioma

July 14, 2003

Promising activity reported for Nipent combination therapy in NHL

July 14, 2003

New antiproliferative agents in Sankyo development pipeline

July 14, 2003

Cytotoxic macrolactones discovered at GBF assumed to act by inhibiting V-ATPase

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.